Ionis Pharmaceuticals, Inc. (0JDI.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
As of 06:58PM BST. Market open.
| Previous close | 42.24 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 351 |
| Market cap | 56.791M |
| Beta (5Y monthly) | 0.40 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.03 |
| Earnings date | 07 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Thomson Reuters StreetEvents
Q1 2024 Ionis Pharmaceuticals Inc Earnings Call
Q1 2024 Ionis Pharmaceuticals Inc Earnings Call
- GuruFocus.com
Ionis Pharmaceuticals Inc (IONS) Q1 2024 Earnings Call Transcript Highlights: Key Developments ...
Explore the pivotal updates from Ionis Pharmaceuticals, including new drug launches, robust pipeline progress, and strategic financial positioning in Q1 2024.
ZacksIonis Pharmaceuticals (IONS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Ionis Pharmaceuticals (IONS) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
© 2024 Yahoo. All rights reserved.